Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand

Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment

NCT01530334 ·Status: COMPLETED ·Phase: PHASE2

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

NCT00322452 ·Status: COMPLETED ·Phase: PHASE3

Iressa as Second Line Therapy in Advanced NSCLC-Asia

NCT00478049 ·Status: COMPLETED ·Phase: PHASE3

Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)

NCT00770588 ·Status: COMPLETED ·Phase: PHASE4

Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

NCT01103089 ·Status: COMPLETED

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic

NCT00127829 ·Status: COMPLETED ·Phase: PHASE1

Iressa Case Control Study in Japan

NCT00252759 ·Status: COMPLETED

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

NCT00234442 ·Status: TERMINATED ·Phase: PHASE2

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

NCT00104728 ·Status: TERMINATED ·Phase: NA

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

NCT00234468 ·Status: TERMINATED ·Phase: PHASE3

Iressa 2nd Line Phase III Study in Japan

NCT00252707 ·Status: COMPLETED ·Phase: PHASE3

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

NCT00455936 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

NCT01000740 ·Status: COMPLETED ·Phase: PHASE4

Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00411047 ·Status: COMPLETED ·Phase: PHASE2

Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)

NCT01312337 ·Status: UNKNOWN ·Phase: PHASE2

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

NCT00173875 ·Status: COMPLETED ·Phase: PHASE2

Iressa v BSC (Best Supportive Care) in First Line NSCLC

NCT00259064 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

NCT00333294 ·Status: COMPLETED ·Phase: PHASE2

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00080340 ·Status: COMPLETED ·Phase: PHASE3

Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study

NCT00242801 ·Status: COMPLETED ·Phase: PHASE3

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa

NCT01448187 ·Status: COMPLETED

Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01391260 ·Status: UNKNOWN ·Phase: PHASE2

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00091156 ·Status: TERMINATED ·Phase: PHASE3

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

NCT01570296 ·Status: COMPLETED ·Phase: PHASE1

Phase II Iressa & Carbo/Gem in NSCLC

NCT00264498 ·Status: COMPLETED ·Phase: PHASE2